This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

PHASE3CompletedINTERVENTIONAL
Enrollment

544

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

October 1, 2021

Study Completion Date

July 26, 2022

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

secukinumab

Secukinumab 300mg every 2 or every 4 weeks

DRUG

Placebo

Placebo 300mg every 2 or every 4 weeks

Trial Locations (111)

1070

Novartis Investigative Site, Brussels

1085

Novartis Investigative Site, Budapest

1104

Novartis Investigative Site, Quezon City

1205

Novartis Investigative Site, Geneva

1606

Novartis Investigative Site, Sofia

1740

Novartis Investigative Site, Las Piñas

2606

Novartis Investigative Site, Phillip

3002

Novartis Investigative Site, East Melbourne

3010

Novartis Investigative Site, Bern

4020

Novartis Investigative Site, Linz

4190

Novartis Investigative Site, Košice

4217

Novartis Investigative Site, Benowa

6000

Novartis Investigative Site, Stara Zagora

7623

Novartis Investigative Site, Pécs

8000

Novartis Investigative Site, Davao City

10002

Novartis Investigative Site, Taipei

11000

Novartis Investigative Site, Prague

11009

Novartis Investigative Site, Cadiz

12462

Novartis Investigative Site, Athens

14467

Novartis Investigative Site, Potsdam

20122

Novartis Investigative Site, Milan

27310

Novartis Investigative Site, Gaziantep

27516

Novartis Investigative Site, Chapel Hill

28041

Novartis Investigative Site, Madrid

28942

Novartis Investigative Site, Fuenlabrada

29407

Novartis Investigative Site, Charleston

29609

Novartis Investigative Site, Brest

30460

Novartis Investigative Site, Pilsen

31400

Novartis Investigative Site, Toulouse

33075

Novartis Investigative Site, Bordeaux

33125

Novartis Investigative Site, Miami

33305

Novartis Investigative Site, Taoyuan District

33612

Novartis Investigative Site, Tampa

33647

Novartis Investigative Site, Bielefeld

34295

Novartis Investigative Site, Montpellier

35205

Novartis Investigative Site, Birmingham

36003

Novartis Investigative Site, Pontevedra

41124

Novartis Investigative Site, Modena

44093

Novartis Investigative Site, Nantes

44657

Novartis Investigative Site, Guadalajara

44791

Novartis Investigative Site, Bochum

45324

Novartis Investigative Site, Fairborn

50122

Novartis Investigative Site, Florence

55112

Novartis Investigative Site, New Brighton

56124

Novartis Investigative Site, Pisa

60077

Novartis Investigative Site, Glenview

60118

Novartis Investigative Site, West Dundee

60590

Novartis Investigative Site, Frankfurt

64460

Novartis Investigative Site, Monterrey

64506

Novartis Investigative Site, Saint Joseph

69437

Novartis Investigative Site, Lyon

72758

Novartis Investigative Site, Rogers

75475

Novartis Investigative Site, Paris

78229

Novartis Investigative Site, San Antonio

80377

Novartis Investigative Site, München

87700

Novartis Investigative Site, Memmingen

89129

Novartis Investigative Site, Langenau

92123

Novartis Investigative Site, San Diego

92807

Novartis Investigative Site, Anaheim

94010

Novartis Investigative Site, Créteil

150003

Novartis Investigative Site, Yaroslavl

197022

Novartis Investigative Site, Saint Petersburg

350020

Novartis Investigative Site, Krasnodar

420012

Novartis Investigative Site, Kazan'

570001

Novartis Investigative Site, Mysore

575002

Novartis Investigative Site, Mangalore

4941492

Novartis Investigative Site, Petah Tikva

9112001

Novartis Investigative Site, Jerusalem

02215

Novartis Investigative Site, Boston

15213-3403

Novartis Investigative Site, Pittsburgh

37072-2301

Novartis Investigative Site, Goodlettsville

75246-1613

Novartis Investigative Site, Dallas

C1425BEA

Novartis Investigative Site, Ciudad Autonoma de Bs As

B1902COS

Novartis Investigative Site, La Plata

C1425DKG

Novartis Investigative Site, Buenos Aires

A 1090

Novartis Investigative Site, Vienna

N6H 5L5

Novartis Investigative Site, London

K9J 5K2

Novartis Investigative Site, Peterborough

N2J 1C4

Novartis Investigative Site, Waterloo

06108

Novartis Investigative Site, Halle

546 43

Novartis Investigative Site, Thessaloniki

422 101

Novartis Investigative Site, Nashik

110 060

Novartis Investigative Site, New Delhi

467-8602

Novartis Investigative Site, Nagoya

292-8535

Novartis Investigative Site, Kisarazu

903 0215

Novartis Investigative Site, Nakagami

343-8555

Novartis Investigative Site, Koshigaya

173-8610

Novartis Investigative Site, Itabashi-ku

545-8586

Novartis Investigative Site, Osaka

02 495

Novartis Investigative Site, Warsaw

42 624

Novartis Investigative Site, Ossy

50 566

Novartis Investigative Site, Wroclaw

1169 050

Novartis Investigative Site, Lisbon

1998-018

Novartis Investigative Site, Lisbon

4454 513

Novartis Investigative Site, Matosinhos Municipality

4099-001

Novartis Investigative Site, Porto

03659

Novartis Investigative Site, Martin

02841

Novartis Investigative Site, Seoul

03080

Novartis Investigative Site, Seoul

07441

Novartis Investigative Site, Seoul

03010

Novartis Investigative Site, Alicante

08041

Novartis Investigative Site, Barcelona

751 85

Novartis Investigative Site, Uppsala

07070

Novartis Investigative Site, Antalya

09100

Novartis Investigative Site, Aydin

M6 8HD

Novartis Investigative Site, Salford

LS7 4SA

Novartis Investigative Site, Leeds

S75 2EP

Novartis Investigative Site, Barnsley

BS2 8HN

Novartis Investigative Site, Bristol

EX2 5DW

Novartis Investigative Site, Exeter

NR4 7UY

Novartis Investigative Site, Norwich

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY